Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which contact lens is better for your Child's nearsightedness?

NCT ID NCT06611410

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested two types of daily disposable contact lenses—Buttermere and MiSight 1 Day—in 10 children and teenagers with myopia (nearsightedness). Each participant wore one lens type for a week, then switched to the other for a week. Researchers measured how clearly they could see and how good their vision felt. The goal was to see if one lens performed better in everyday use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
stenfilcon A and omafilcon A contact lenses
What this could lead to
If successful, this could show that one lens provides better vision or comfort for young people with myopia.
What could go wrong
This was a very small, short-term study with only 10 participants, so results may not apply to everyone. It does not test long-term effects or myopia progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Jun 2024

Finished

Jul 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are 8 to 18 years of age (inclusively) * Have read, signed and dated: * Age 18 - The Participant Informed Consent Form (participant only) * Age 12-17 - The Parental Permission Form (participant and parent) * Age 8-11 - The Parental Permission Form (parent) and Assent form (participant) * Are willing and able to follow instructions and maintain the appointment schedule. * Are habitual daily wearers of spherical single vision soft contact lenses to correct for distance vision in each eye, including myopia control soft contact lenses as below- * Currently wears spherical soft contact lenses or myopia control soft contact lenses. * Have a pair of wearable back-up spectacles. * Are willing and able to wear contact lenses for at least 10 hours a day, 6 days a week while in the study. * Are myopic with subjective refraction: -0.75D to -7.00D spherical, with an astigmatism ≤ -0.75D in each eye with maximum spherical equivalent anisometropia of 1.00D * Are correctable to a visual acuity of +0.10 logMAR or better (in each eye) with sphero-cylindrical subjective refraction. * Have clear corneas with no corneal scars or any active ocular disease. * Can be fit with the study contact lenses with a power between -0.75 and -7.00 DS; this translates to best corrected vision sphere refraction that vertexes to a CL power between -0.75 and -7.00 (inclusive) at screening visit. * Demonstrate an acceptable fit with the study contact lenses. * Demonstrate that they can safely and independently insert and remove contact lenses at the screening/fitting visit. Exclusion Criteria: * Have taken part in another clinical research study within the last 14 days. * Are currently habitual wearers of toric contact lenses. * Have worn any rigid contact lenses or ortho-keratology contact lenses in the past 30 days. * Are an extended contact lens wearer (i.e., sleeping with their contact lenses). * Are on ongoing atropine treatment for myopia control. * Have a difference of \> 1.0 D in best vision sphere subjective refraction between eyes. * Have amblyopia and/or strabismus/binocular vision problem. * Have any known active ocular disease, allergies and/or infection. * Have a systemic condition that in the opinion of the investigator may affect a study outcome variable. * Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. * Have a known sensitivity to the diagnostic pharmaceuticals to be used in the study. * Have undergone refractive error surgery or intraocular surgery. * Are a member of CORL directly involved in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Optics Research Lab (CORL)

    Bloomington, Indiana, 47405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.